About MedTherapy
MedTherapy is a company based in Quincy (United States) founded in 2018. MedTherapy operates in a competitive market with competitors including Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others.
- Headquarter Quincy, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website medtherapybiotech.com
- Social LinkedIn
- Legal Name Medtherapy Biotechnology (India) Private Limited
- Date of Incorporation 18 Feb, 2020
- Jurisdiction Noida, Uttar Pradesh, India
- Annual Revenue₹5.18 Cr
FY 2025 · +15479% YoY
- Net Loss-₹9.19 Cr
FY 2025 · -177% margin
- EBITDA-₹7.67 Cr
FY 2025 · -148% margin
Associated legal entities of MedTherapy
MedTherapy operates through Medtherapy Biotechnology (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medtherapy Biotechnology (India) Private Limited CIN U24110UP2020FTC170983 | Active | 18 Feb 2020 | Noida, Uttar Pradesh | ₹5.2 Cr | 32 | 2 | View details |
Board of directors of Medtherapy Biotechnology (India) Private Limited (MedTherapy)
Medtherapy Biotechnology (India) Private Limited is the primary company behind MedTherapy. The board of Medtherapy Biotechnology (India) Private Limited currently have 2 directors; the longest-serving is Bikash Kumar Verma, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bikash Kumar Verma DIN 08702731 | Director | 18 Feb 2020 | 6 yrs 7 mo | Medtherapy Biotechnology (India) Private Limited |
| Vijayabhaskar Reddy Kandula DIN 08702732 | Director | 18 Feb 2020 | 6 yrs 7 mo | Medtherapy Biotechnology (India) Private Limited |
People of MedTherapy
17 people are tracked at MedTherapy (6 in leadership, 11 in board & advisors).
| Name | Role | Group |
|---|---|---|
Sanjay Singh | Managing Director | Leadership |
| CEO & CMO | Leadership | |
Moran Ben David Shapira | VP, Business Development | Leadership |
John Anderson | CFO | Leadership |
Antoine Heron | Head of Cell Therapy Commercial Strategy | Leadership |
Graham Morrell | Head, Investor Relations | Leadership |
Daniel J. Deangelo | Director | Board & advisors |
| Director | Board & advisors | |
Ravi Kant | Advisor | Board & advisors |
David Wald | Advisor | Board & advisors |
Krishna G. Palepu | Advisor | Board & advisors |
Martin Pule | Advisor | Board & advisors |
Yi-Bin Chen | Advisor | Board & advisors |
Gary P. Pisano | Advisor | Board & advisors |
Caron Jacobson | Advisor | Board & advisors |
Julia Romm | Director | Board & advisors |
Robert Brooks | Director | Board & advisors |
Complete people profiles for MedTherapy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of MedTherapy
Figures of Medtherapy Biotechnology (India) Private Limited, the primary company behind MedTherapy, for FY 2025. Revenue was ₹5.18 Cr (+15479% year on year). Net loss was -₹9.19 Cr (-177% margin). EBITDA was -₹7.67 Cr (-148% margin).
- ₹5.18 CrRevenue · FY 2025 · +15479% YoY
- -₹9.19 CrNet loss · -177% margin
- -₹7.67 CrEBITDA · -148% margin
- ₹6.92 CrPaid-up capital
- 32Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Medtherapy Biotechnology (India) Private Limited are on its company page.
Detailed financial statements for MedTherapy
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of MedTherapy
MedTherapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| orgenesis.com | 2008 | Germantown, United States | – | 167 | Cell and gene therapies for multiple disorders are developed. | |
| oribiotech.com | 2015 | London, United Kingdom | $281.12M | 52 | Software development services are provided for the biopharma sector. | |
| masthercell.com | 2011 | Charleroi, Belgium | $17.37M | 329 | Services for cell therapy development and manufacturing are provided. | |
| cognatebioservices.com | 2002 | Hanover, United States | – | 302 | Development and manufacturing services for cell-based therapies are provided. | |
| cell-easy.com | 2015 | Toulouse, France | – | – | Stem cell-based therapy services for research solutions are provided. | |
| genflowbio.com | 2020 | Charleroi, Belgium | – | 5 | A biotechnology company focused on anti-aging therapeutics development. | |
| exothera.world | 2020 | Brussels, Belgium | – | 131 | Clinical trial services to biopharma sector are provided by CDMO. | |
| splisense.com | 2016 | Jerusalem, Israel | $28.5M | – | Limited information available | |
| exmoorpharma.com | 2004 | Bristol, United Kingdom | $51.75M | – | Cell and gene therapeutic services are provided to biopharmaceutical firms. |
Detailed competitors of MedTherapy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MedTherapy
The website of MedTherapy (medtherapybiotech.com) receives about 5.9K visits a month.
- Monthly visits5.9K
▲ 1760.6% vs previous month
Websites whose visitors overlap most with MedTherapy. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nchromabio.com | 100% | 3.3K | #5,351,318 | View details | |
| ensoma.com | 94% | 2.8K | #4,644,561 | View details | |
| keloniatx.com | 92% | 5.7K | #3,190,311 | View details | |
| vedantabio.com | 85% | 5.6K | #3,168,764 | View details |
Latest news on Medtherapy
Complete news archive for MedTherapy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to MedTherapy
10 companies that operate in the same segment as MedTherapy (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MedTherapy
MedTherapy was founded in 2018.
MedTherapy is headquartered in Quincy, United States.
Bikash Verma is the current CEO of MedTherapy.
The primary company behind MedTherapy, Medtherapy Biotechnology (India) Private Limited, reported revenue of ₹5.18 Cr for FY 2025, up 15479% year on year.
MedTherapy was founded in 2018 and is based in Quincy, United States. Operations are centered in the biotechnology sector, where manufacturing services for cell and gene therapies are offered. CAR-T cell therapies and viral vectors are produced, along with related support services, to address cancer treatment needs. Accessibility to these therapies is targeted for patients globally through established processes.
MedTherapy's top competitors include Ori Biotech, MaSTherCell and Genflow Biosciences.
MedTherapy operates through Medtherapy Biotechnology (India) Private Limited.
The legal entities of MedTherapy currently have 2 directors, including Bikash Kumar Verma, Vijayabhaskar Reddy Kandula.